Factors Influencing Men Undertaking Active Surveillance for the Management of Low-Risk Prostate Cancer

被引:75
作者
Davison, B. Joyce [1 ,2 ]
Oliffe, John L. [3 ]
Pickles, Tom [4 ]
Mroz, Lawrence
机构
[1] Univ British Columbia, Dept Urol, Vancouver, BC V5Z 1M9, Canada
[2] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, Sch Nursing, Vancouver, BC V5Z 1M9, Canada
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
基金
加拿大健康研究院;
关键词
QUALITY-OF-LIFE; SELECTIVE DELAYED INTERVENTION; RADICAL PROSTATECTOMY; EXPECTANT MANAGEMENT; CAPSURE; INFORMATION; CARCINOMA; PARTNERS; BRACHYTHERAPY; PREFERENCES;
D O I
10.1188/09.ONF.89-96
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose/Objectives: To identify and describe decision-making influences on men who decide to manage their low-risk prostate cancer with active surveillance. Research Approach: Qualitative, semistructured interview. Setting: The Prostate Centre at Vancouver General Hospital in Canada. Participants: 25 patients diagnosed with low-risk prostate cancer and on active Surveillance. Methodologic Approach: An interpretative, descriptive, qualitative design. Main Research Variables: Factors that influenced men's decisions to take up active surveillance. Findings: The specialists' description of the prostate cancer was the most influential factor on men choosing active surveillance. Patients did not consider their prostate cancer to be life threatening and, in general, were relieved that no treatment was required. Avoiding treatment-related suffering and physical dysfunction and side effects such as impotence and incontinence was cited as the major reason to delay treatment. Few men actively sought treatment or health-promotion information following their treatment decision. Female partners played a supportive role in the decision. The need for active treatment if the cancer progressed was acknowledged. Patients were hopeful that new treatments would be available when and if they needed them. Being older and having comorbidities did not preclude the desire for future active treatment. Patients carried on with their lives as usual and did not report having any major distress related to being on active surveillance. Conclusions: The study findings indicate that men are strongly influenced by the treating specialist in taking up active surveillance and planning future active treatments. As such, most men relied on their specialists' recommendation and did not perceive the need for any adjunct therapy or support until the cancer required active treatment. Interpretation: Oncology nurses should work collaboratively with specialists to ensure that men receive the information they need to make informed treatment decisions.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 33 条
  • [1] How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium
    Altwein, J
    Ekman, P
    Barry, M
    Biermann, C
    Carlsson, P
    Fossa, S
    Kiebert, G
    Kuchler, T
    McLeod, D
    Porter, A
    Steineck, G
    [J]. UROLOGY, 1997, 49 (4A) : 66 - 76
  • [2] Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from CaPSURE
    Arredondo, SA
    Downs, TM
    Lubeck, DP
    Pasta, DJ
    Silva, SJ
    Wallace, KL
    Carroll, PR
    [J]. JOURNAL OF UROLOGY, 2004, 172 (05) : 1830 - 1834
  • [3] Watching, waiting and uncertainty in prostate cancer
    Bailey, Donald E., Jr.
    Wallace, Meredith
    Mishel, Merle H.
    [J]. JOURNAL OF CLINICAL NURSING, 2007, 16 (04) : 734 - 741
  • [4] What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance?: An analysis of the CaPSURE™ database
    Barocas, Daniel A.
    Cowan, Janet E.
    Smith, Joseph A.
    Carroll, Peter R.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (04) : 1330 - 1334
  • [5] Radical prostatectomy versus watchful waiting in early prostate cancer
    Bill-Axelson, A
    Holmberg, L
    Ruutu, M
    Häggman, M
    Andersson, SO
    Bratell, S
    Spångberg, A
    Busch, C
    Nordling, S
    Garmo, H
    Palmgren, J
    Adami, HO
    Norlén, BJ
    Johansson, JE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) : 1977 - 1984
  • [6] Expectant management of prostate cancer with curative intent: An update of the Johns Hopkins experience
    Carter, H. Ballentine
    Kettermann, Anna
    Warlick, Christopher
    Metter, E. Jeffrey
    Landis, Patricia
    Walsh, Patrick C.
    Epstein, Jonathan I.
    [J]. JOURNAL OF UROLOGY, 2007, 178 (06) : 2359 - 2364
  • [7] Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study
    Chapple, A
    Ziebland, S
    Herxheimer, A
    Mcpherson, A
    Shepperd, S
    Miller, R
    [J]. BJU INTERNATIONAL, 2002, 90 (03) : 257 - 264
  • [8] The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management
    Cooperberg, MR
    Lubeck, DP
    Meni, MV
    Mehta, SS
    Carroll, PR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2141 - 2149
  • [9] Davison B Joyce, 2003, Oncol Nurs Forum, V30, P107, DOI 10.1188/03.ONF.107-114
  • [10] Empowerment of men newly diagnosed with prostate cancer
    Davison, BJ
    Degner, LF
    [J]. CANCER NURSING, 1997, 20 (03) : 187 - 196